Effect of Helicobacter pylori infection on fibrinogen level in elderly patients with ischaemic heart disease

Acta Cardiologica

Volumn 57, Issue 5, 2002, Pages 317-322

  Yusuf, Syed W ^a   Mishra, Radha M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Elderly; Fibrinogen; Heart disease; Helicobacter pylori; Ischaemic

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; FIBRINOGEN; OMEPRAZOLE; PROTON PUMP INHIBITOR;

AGED; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FIBRINOGEN BLOOD LEVEL; GERIATRIC PATIENT; HELICOBACTER PYLORI; HUMAN; ISCHEMIC HEART DISEASE; PEPTIC ULCER; PROGNOSIS; TREATMENT OUTCOME; UREA BREATH TEST;

EID: 0036791816     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.57.5.2005446     Document Type: Article

References (34)

1. Yarnell JWG, Baker IA, Sweetnam PM, Bainton D, O'Brien JR, Whitehead PJ, Elwood PC. Fibrinogen viscosity and white blood cell count are major risk factors for ischaemic heart disease. Circulation 1991; 83: 836-44.
2. Patel P, Carrington D, Strachan DP, Leatham E, Goggin P, Northfield TC, Mendall MA. Fibrinogen a link between chronic infection and coronary heart disease. Lancet 1994; 343: 1634-5.
3. Patel P, Mendall MA, Carrington D, Strachan DP, Leatham E, Molineaux N, Levy J, Blakeston C, Seymour CA, Camm AJ, Northfield TC. Association of Helicobacter pylori and Chlamydia pneumoniae with coronary heart disease and cardiovascular risk factors. BMJ 1995; 311: 711-4.
4. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, Camm AJ, Northfield TC. Relation of Helicobacter pylori and coronary heart disease. Br Heart J 1994; 71: 437-9.
5. Pasceri V, Cammarota G, Patti G, Cuoco L, Gasbarrini A, Grillo RL, Fedeli G, Gasbarrini G, Maseri A. Association of virulent Helicobacter pylori strains with ischaemic heart disease. Circulation 1998; 97: 1675-9.
6. Toss H, Lindahl B, Siebahn A, Wallentin L. For the FRISC Study Group. Prognostic influence of increased fibrinogen and C-reactive protein in unstable coronary artery disease. Circulation 1997; 96: 4204-10.
7. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin and risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-9.
8. Strandberg TE, Tilvis RS, Vuoristo M, Lindroos M, Kosunen TU. Prospective study of Helicobacter pylori seropositivity and cardiovascular diseases in a general elderly population. BMJ 1997; 314: 1317-8.
9. Strachan DP, Mendall MA, Carrington D, Butland BK, Yarnell JWG, Sweetnam PM, Elwood PC. Relation of Helicobacter pylori infection to 13-year mortality and incident ischaemic heart disease in the Caerphilly Prospective Heart Disease Study. Circulation 1998; 98: 1286-90.
10. Thompson SG, Kienast MAJ, Pyke SDM, Haverkate F, Van De Loo JCW. For the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Haemostatic factors and the risk of myocardial infarction in patients with angina pectoris. New Engl J Med 1995; 332: 635-41.
11. Mehta JL, Saldeen TGP, Rand K. Interactive role of infection inflammation and traditional risk factors in atherosclerosis and coronary artery disease. J Am Coll Cardiol 1998: 31: 1217-25.
12. Danesh J, Collins R, Peto R. Chronic infection and coronary heart disease. Is there a link? Lancet 1997; 350: 430-6.
13. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-26.
14. Koenig W, Rothenbacher D, Hoffmeister A, Miller A, Bode G, Adler G, Hombach V, Marz W, Pepys MB, Brenner H. Chronic infection with Helicobacter pylori is associated with the risk of coronary heart disease. Result of a case control study. Gut 1998; suppl 2; (23): A104.
15. Folsom AR, Nieto J, Sorlie P, Chambless LE, Graham DY. Helicobacter pylori seropositivity and coronary heart disease incidence. Circulation 1998; 98: 845-50.
16. Danesh J, Peto R. Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. BMJ 1998; 316: 1130-2.
17. Koenig W, Rothenbacher D, Hoffmeister A, Miller M, Bode G, Adler G, Hombach V, Marz W, Pepys MB, Brenner H. Infection with Helicobacter pylori is not a major independent risk factor for stable coronary heart disease. Circulation 1999; 100: 2326-31.
18. Whincup P, Danesh J, Walker M, Lennon L, Thomson A, Appleby P, Hawkey C, Atherton J. Prospective study of potentially virulent strains of Helicobacter pylori and coronary heart disease in middle-aged men. Circulation 2000; 101: 1647-52.
19. Stone AF, Risley P, Markus HS, Butland BK, Strachan DP, Elwood PC, Mendall MA. Ischaemic heart disease and Cag A strains of Helicobacter pylori in the Caerphilly heart disease study. Heart 2001; 86: 506-9.
20. Gunn M, Stephens JC, Thompson JR, Rathbone BJ, Samani NJ. Significant association of CagA positive Helicobacter pylori strains with risk of premature myocardial infarction. Heart 2000; 84: 267-71.
21. Pellicano R, Mazzarello MG, Morelloni S, Allegri M, Arena V, Ferrari M, Rizzetto M, Ponzetto A. Acute myocardial infarction and Helicobacter pylori seropositivity. Int J Clin Lab Res 1999; 29: 141-4.
22. Hara K, Morita Y, Kamihata H, Iwasaka T, Takahashi H. Evidence for infection with Helicobacter pylori in patients with acute myocardial infarction. Clinica Chemica Acta 2001; 313: 87-94.
23. Rupprecht H, Blakenberg S, Bickel C, Rippin G, Gerd H, Prellwitz W, Schlumberger W, Meyer J; for the AtheroGene Investigators. Impact of viral and bacterial infection burden on long-term prognosis in patients with coronary artery disease. Circulation 2001; 104: 25-31.
24. Zito F, DiCastelnuovo A, D'Orazio A, Negrini R, DeLucia D, Donati MB, Lacoviello L. Helicobacter pylori infection and the risk of myocardial infarction: role of fibrinogen and its genetic control. Thromb Haemost 1999; 82(1): 14-8.
25. Miragliotta G, Prete RD, Mosca A. Helicobacter infection and coronary heart disease. Lancet 1994; 344: 751.
26. Elizalde JI, Gomez J, Panes J, Lozano M, Casadevall M, Pizcueta P, Granger DN, Pique JM. Platelet activation in human Helicobacter pylori infection. A link to coronary heart disease. Gastroenterology 1997; 112 (suppl): A111.
27. Takemura T, Granger DN, Evans DJ Jr., Evans DG, Graham DY, Anderson DC, Wolf RE, Cepinskas G, Kvietys PR. Extract of helicobacter pylori induces neutrophils to injure endothelial cells and contains antielastase activity. Gastroenterology 1996; 110: 21-9.
28. Birnie D, Holme ER, McKay IC, Hood S, McColl KEL, Hillis WS. Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Eur Heart J 1998; 19: 387-94.
29. Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B. For the ROXIS Study Group. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. Lancet 1997; 350: 404-7.
30. Ridker PM. The pathogenesis of atherosclerosis and acute thrombosis. Relevance to strategies of cardiovascular prevention. In Mason JE, Ridker PM, Hennekem CH. Prevention of myocardial infarction. Oxford Univ Press 1996; p. 32-54.
31. Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WR, Haines AP, Stirling Y, Imeson JD, Thompson SG. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 2(8506): 533-7.
32. Crabtree JRE. Immune and inflammatory response to Helicobacter pylori infection. Scand J Gastroenterol 1996; 31 (suppl): 3-10.
33. Gasbarrini A, De Luca A, Fiore G, Gambrielli M, Franceschi F, Ojetti V, Torre ES, Gasbarrini G, Pola P, Giacovazzo M. Beneficial effects of Helicobacter pylori eradication on migraine. Hepatogastroenterology 1998; 45 (21): 765-70.
34. Gasbarrini A, Massari I, Serricchio M, Tondi P, De Luca A, Franceschi F, Ojetti V, Dal Lago A, Flore R, Santoliquido A, Gasbarrini G, Pola P. Helicobacter pylori eradication ameliorates primary Raynaud's phenomenon. Dig Dis Sci 1998; 43(8): 1641-5.